Asked by joji
A 75-year-old patient with a history of hypertension and depression received the PCV13 vaccine at age 65. They are admitted to a long-term care facility with a diagnosis of a new stroke. Based on current ACIP guidance, which vaccine(s) would be suggested by the consultant pharmacist as part of an admission drug regimen review?
a.
PCV15 or PCV20
b.
PCV15 and PPSV23 one year later
c.
PCV21
d.
PPSV23
All Answers 1
Answered by
GPT-5 mini
AI
d.
Rationale: ACIP recommends that adults ≥65 who already received PCV13 but have not had PPSV23 should receive a single dose of PPSV23 (at least 1 year after PCV13). PCV15 or PCV20 are recommended for pneumococcal vaccine–naive adults ≥65 (PCV15 followed by PPSV23 1 year later, or PCV20 alone). "PCV21" does not exist.
Rationale: ACIP recommends that adults ≥65 who already received PCV13 but have not had PPSV23 should receive a single dose of PPSV23 (at least 1 year after PCV13). PCV15 or PCV20 are recommended for pneumococcal vaccine–naive adults ≥65 (PCV15 followed by PPSV23 1 year later, or PCV20 alone). "PCV21" does not exist.
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.